ropeginterferon alpha-2b as an effective treatment against pv
Published 6 years ago • 5.6K plays • Length 3:00Download video MP4
Download video MP3
Similar videos
-
1:49
current and future therapies for pv: ropeginterferon alfa-2b
-
1:56
5-year follow up results of long-term use of ropeginterferon alfa-2b in polycythemia vera
-
1:29
ropeginterferon alfa-2b for polycythemia vera: impacts and considerations
-
2:45
the value of axi-cel as a second-line treatment in r/r lbcl
-
4:31
ropeginterferon alfa-2b in patients with pre-fibrotic primary mf & dipss low/intermediate-1 risk mf
-
2:40
safety and efficacy of ropeginterferon alfa-2b for pre-fibrotic primary myelofibrosis
-
4:30
update on the use of interferon-alfa for polycythemia vera
-
26:22
key takeaways in mpns
-
8:11
what is hematology oncology?
-
5:56
hematologic system examination
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
2:05
ropeg in polycythemia vera: long-term proud-pv and conti-pv results
-
0:56
rop-et: a phase iii non-randomized study of ropeginterferon alfa-2b in patients with et
-
1:41
updates on ropeginterferon in mpns
-
2:06
clinical updates on the use of ropeginterferon for polycythemia vera
-
3:10
promising trials in polycythemia vera
-
2:39
targeting jak2 v617f in mpns with interferon alpha and arsenic trioxide
-
4:45
phase ib/ii multi-arm study of combinations of novel agents in r/r aml
-
2:28
proud-pv and mpd-rc 112 trials of interferon alpha vs hydroxyurea for mpns
-
4:34
pv highlights at ash 2020
-
2:41
an overview of the latest advances in hematology